leadf
logo-loader
viewExro Technologies
(
TSX-V:EXROOTCQB:EXROF
)

Full interview: Exro Technologies preparing for a busy 2020 after taking big steps forward in 2019

Exro Technologies (CSE: XRO) CSE Sue Ozdemir sat down with Steve Darling from Proactive Vancouver to discuss the company’s plan for a very productive 2020. Ozdemir discussed what milestones she is looking at for 2020 which includes a number of deals.

Ozdemir also told Proactive about a major step forward for the company as far as proof of concept is concerned. 

Quick facts: Exro Technologies

Follow
TSX-V:EXRO

Price: - -

Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

BioVaxys preps for Phase 1 study as vaccine manufacturing partner reaches...

BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) COO Kenneth Kovan tells Proactive that cancer vaccine manufacturing partner Bio Elpida has reached major milestones in the development of the bioproduction process for BVX-0918A, BioVaxys’ ovarian cancer vaccine. Kovan says the Lyon,...

1 day, 10 hours ago

2 min read